Drug Type Fusion protein |
Synonyms JR 471, JR471 |
Target |
Action antagonists |
Mechanism TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Fucosidosis | Preclinical | Japan | 18 Jul 2023 |






